In an article published this week in NEJM Catalyst, Kaiser Permanente physicians and leaders acknowledge the conundrum of reopening the country for business while preventing successive waves of coronavirus infection, and describe the next strategic phase in the battle against the COVID-19 pandemic: disease suppression.
Vincent Liu, MD, a specialist in critical care medicine with The Permanente Medical Group, commented on a Kaiser Permanente study that found important differences in outcomes among hospitalized COVID-19 patients in the western United States and other parts of the world.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.
Stephen M. Parodi, MD, and Vincent Liu, MD, both of The Permanente Medical Group, published a peer-reviewed viewpoint online in JAMA on the urgent need for public health officials and large health care systems to move from containment to mitigation of the new coronavirus that causes COVID-19.
Vincent Liu, MD, MSc, discusses his research on sepsis, a stealthy killer of people of all ages who are hospitalized.
A group of physicians, including Vincent Liu, MD, MS, research scientist at Kaiser Permanente Division of Research in Northern California, recently published a roadmap for the responsible use of machine-learning-based interventions.